Just read their latest announcement. China problem continues and won't be resolved quickly. Money is obviously a big problem now. I note their voluntary pay cuts though they aren't the first biotech to do this. They've put in a few estimations of time for resolution of various things but I'm guessing you could double those. Not relisting any time soon and i would think they are in big trouble. Yes I also have no idea where they are going to financing a long and expensive thromboview trial. To me it looks very bleak.
- Forums
- ASX - By Stock
- CT1
- due an update
due an update, page-6
Featured News
Add CT1 (ASX) to my watchlist
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.212M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $75 | 50K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
27 | 21732062 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 2889129 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 21732062 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 2889129 | 5 |
0.003 | 5429081 | 8 |
0.004 | 5344996 | 5 |
0.005 | 2000000 | 1 |
0.007 | 2500000 | 2 |
Last trade - 13.02pm 05/09/2024 (20 minute delay) ? |
Featured News
CT1 (ASX) Chart |